Synthetic adjuvants to potentiate the immune response against rAg85B by nasal route.
Rong Chen, Changyuan Tan, Wen Li, Yasser Perera, Yadira Lobaina
This study evaluates two synthetic adjuvants, ODN-39M and LALF32-51, for enhancing immune response against Mycobacterium tuberculosis Ag85B via nasal vaccination in mice, showing ODN-39M's effectiveness in inducing Th1 and mucosal immunity.
bioRxiv · Sep 4, 2026 · PreprintImmunology